SJ Medical
SJ Medical
Russia faces significant clinical challenges regarding Cardiovascular Disease (CVD) and Peripheral Artery Disease (PAD). As the Russian Ministry of Health (Minzdrav) continues to modernize regional clinics through the "Healthcare" National Project, the demand for advanced Atherectomy Systems has skyrocketed. These systems are essential for plaque excision in heavily calcified vessels, a common condition among the aging Russian demographic.
Our role as a leading supplier and exporter involves navigating the unique regulatory environment of the Eurasian Economic Union (EAEU). We ensure that our vascular interventional devices meet the rigorous GOST-R and EAC standards, providing Russian surgeons in Moscow, Novosibirsk, and Kazan with the tools they need for minimally invasive revascularization.
Established in 2015, Hangzhou SJ Medical Co., Ltd. has rapidly emerged as a powerhouse in the research, development, and manufacturing of vascular interventional medical devices. Our expertise spans both cardiovascular and peripheral interventions, allowing us to export high-end Atherectomy components and systems to complex markets like Russia.
Our commitment to E-E-A-T principles is reflected in our robust R&D pipeline. By integrating interventional access systems with diagnostic catheters, we provide a holistic solution. In Russia, where "import substitution" is a key trend, SJ Medical acts as a reliable partner by offering OEM and ODM services that allow local Russian medical brands to maintain high technological standards while optimizing costs.
Operating a million-class clean workshop, SJ Medical utilizes localized hundred-class areas for critical assembly processes. This precision is vital for Atherectomy systems, where even micron-level inconsistencies can affect clinical outcomes in carotid or femoral artery procedures. Our facility is fully GMP-compliant, ensuring every device exported to the Russian Federation is safe and reliable.
Modern vascular surgery in Russia is moving towards "Zero-Ischemia" and "Limb Salvage" protocols. Atherectomy systems play a pivotal role here. Unlike traditional angioplasty, which might cause vessel wall dissection in calcified Russian patients, atherectomy removes the burden of the plaque.
Our Atherectomy and Interventional products are deployed across various medical scenarios in Russia:
| Application Field | Specific Usage in Russia | Recommended SJ Medical Product |
|---|---|---|
| Peripheral Intervention | Treating Diabetic Foot syndrome in regional Moscow hospitals. | PTA Balloon Dilatation Catheters & Atherectomy Sheaths |
| Coronary Procedures | Complex PCI in federal cardiology centers. | PTCA Balloon Catheters & Inflation Devices |
| Nephrology | Dialysis access maintenance in Ural region clinics. | Hemodialysis Machines & Renal Access Systems |
Each application is backed by our CE, ISO 13485, and CFDA certifications, making the registration process with Roszdravnadzor (Russian Medical Device Regulator) smoother for our partners.
While we focus on the Russian and CIS markets, SJ Medical maintains a strong presence in Europe (Italy, Spain, France), Asia (India, Indonesia), and the Middle East (Turkey, Egypt). This global exposure ensures that we are always at the forefront of international clinical standards, bringing world-class vascular technology to our Russian clients.
Our services include comprehensive pre-sales consultation, ensuring that Russian distributors select the right specification of catheters and stents for their specific tender requirements.
